Pi-Cardia Closes a $27 Million Financing led by Sofinnova Partners to Continue Clinical Trials With Its Leaflex™ Aortic Valve Technology

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3aoNQJh
via IFTTT